Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group.

导出原文传递

翻译打印收藏纠错

作者： Stuart M,Lichtman ^[1] ; R Donald,Harvey ^[1] ; Marie-Anne,Damiette Smit ^[1] ; Atiqur,Rahman ^[1] ; Michael A,Thompson ^[1] ; Nancy,Roach ^[1] ; Caroline,Schenkel ^[1] ; Suanna S,Bruinooge ^[1] ; Patricia,Cortazar ^[1] ; Dana,Walker ^[1] ; Louis,Fehrenbacher ^[1]

作者单位： Stuart M. Lichtman, Memorial Sloan Kettering Cancer Center, Commack, NY; R. Donald Harvey, Emory University School of Medicine, Atlanta, GA; Marie-Anne Damiette Smit and Atiqur Rahman, US Food and Drug Administration, Silver Spring, MD; Michael A. Thompson, Aurora Health Care, Milwaukee, WI; Nancy Roach, Fight Colorectal Cancer, Springfield, MO; Caroline Schenkel and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Patricia Cortazar, Genentech, South San Francisco; Louis Fehrenbacher, Kaiser Permanente Northern California, Vallejo, CA; and Dana Walker, Bristol-Myers Squibb, Philadelphia, PA. ^[1]

主题词生物医学研究(Biomedical Research);共病现象(Comorbidity);合格鉴定(Eligibility Determination);人类(Humans);医学肿瘤学(Medical Oncology);美国(United States)

DOI 10.1200/JCO.2017.74.4102

PMID 28968172

发布时间 2017-11-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交